Brickell Biotech Q3 EPS $(1.65) Up From $(5.98) YoY, Sales $1.183M Down From $3.042M YoY

Brickell Biotech (NASDAQ:BBI) reported quarterly losses of $(1.65) per share. This is a 72.41 percent increase over losses of $(5.98) per share from the same period last year. The company reported $1.183 million in

Benzinga · 11/13/2019 21:15

Brickell Biotech (NASDAQ:BBI) reported quarterly losses of $(1.65) per share. This is a 72.41 percent increase over losses of $(5.98) per share from the same period last year. The company reported $1.183 million in sales this quarter. This is a 61.11 percent decrease over sales of $3.042 million the same period last year.